Observational study / 2019
Higher urinary melamine levels were significantly associated with kidney function deterioration in patients with early-stage CKD.
A prospective cohort study evaluated 293 patients with eGFR ≥30 ml/min per 1.73 m2 followed for a median of 7.0 years. The median urinary corrected melamine level at enrollment was 0.97 μg/mmol. Serum creatinine doubled in 80 subjects (27%), and those in the highest tertile of urinary melamine had a significantly higher hazard risk for doubling of serum creatinine compared with the lowest tertile (hazard risk 2.30; 95% CI, 1.25 to 4.23; P < 0.01). Similar dose-response relationships were observed for eGFR decline >3 ml/min per 1.73 m2 per year and a 30% decline in eGFR in the first 2 years.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 293 patients with early-stage CKD (eGFR ≥30 ml/min per 1.73 m2) enrolled in 2006-2010
- What was measured
- Doubling of serum creatinine, eGFR decline >3 ml/min per 1.73 m2 per year, and 30% eGFR decline in first 2 years
THE PAPER
Urinary Melamine Levels and Progression of CKD.
Tsai YC, Wu CF, Liu CC, Hsieh TJ, Lin YT, Chiu YW, Hwang SJ, Chen HC, Wu MT. Clin J Am Soc Nephrol, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.